Stocks · Health care · Surgical & Medical Instruments & Apparatus

Orchestra BioMed Holdings, Inc.

OBIO Clue Score66
United States Fiscal year ends December CIK 0001814114

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Darren Sherman
2 Nov 2026
See Remarks
Sold on a plan
15,000
$5.74
$86.10K
Darren Sherman
1 Oct 2026
See Remarks
Sold on a plan
15,000
$6.36
$95.40K
David P Hochman
3 Sep 2026
See Remarks
Buy
10,000
$4.79
$47.90K
Darren Sherman
1 Sep 2026
See Remarks
Sold on a plan
15,000
$4.94
$74.10K
Darren Sherman
26 Aug 2026
See Remarks
Buy indirect
2,000
$5.33
$10.66K
Darren Sherman
3 Aug 2026
See Remarks
Sold on a plan
15,000
$4.09
$61.35K
Darren Sherman
1 Jul 2026
See Remarks
Sold on a plan
15,000
$4.27
$64.05K
Darren Sherman
1 Jun 2026
See Remarks
Sold on a plan
15,000
$3.87
$58.05K
David P Hochman
1 Jun 2026
See Remarks
Buy
5,000
$3.83
$19.15K
Jason Aryeh
18 May 2026
Director
Buy
665
$3.75
$2.49K
David P Hochman
15 May 2026
See Remarks
Buy
5,000
$3.77
$18.85K
Jason Aryeh
15 May 2026
Director
Buy
8,971
$3.90
$34.99K
Eric S Fain
14 May 2026
Director
Buy indirect
20,000
$4.13
$82.60K
Rtw Investments, LP
27 Apr 2026
10% owner
Sold after exercise indirect
32
$4.13
$132.16
David P Hochman
13 Mar 2026
See Remarks
Buy
10,000
$4.29
$42.90K
David P Hochman
14 Nov 2025
See Remarks
Buy
5,000
$4.07
$20.35K
Jason Aryeh
19 Sep 2025
Director
Buy
1,000
$2.45
$2.45K
Andrew Lawrence Taylor
25 Aug 2025
Chief Financial Officer
Buy
2,000
$2.55
$5.10K
Darren Sherman
25 Aug 2025
See Remarks
Buy
3,000
$2.62
$7.86K
Eric S Fain
25 Aug 2025
Director
Buy indirect
5,760
$2.61
$15.03K
David P Hochman
21 Aug 2025
See Remarks
Buy
6,000
$2.49
$14.94K
David P Hochman
4 Aug 2025
See Remarks
Buy indirect
20,000
$2.75
$55.00K
Perceptive Advisors LLC
1 Aug 2025
10% owner
Buy indirect
700,000
$2.75
$1.93M
Eric S Fain
26 Jun 2025
Director
Sell indirect
2,683
$3.05
$8.18K
Rtw Investments, LP
30 Apr 2025
10% owner
Buy indirect
49,900
$2.99
$149.20K
Rtw Investments, LP
29 Apr 2025
10% owner
Buy indirect
50,000
$2.53
$126.50K
Jason Aryeh
27 Dec 2024
Director
Exercised, kept
11,700
$4.30
$50.31K
David P Hochman
23 Dec 2024
See Remarks
Buy
4,000
$4.66
$18.64K
Andrew Lawrence Taylor
19 Dec 2024
Chief Financial Officer
Buy
1,000
$4.83
$4.83K
David P Hochman
18 Dec 2024
See Remarks
Buy
5,000
$4.91
$24.55K
David P Hochman
25 Sep 2024
See Remarks
Buy indirect
2,000
$4.73
$9.46K
David P Hochman
25 Sep 2024
See Remarks
Buy indirect
2,000
$4.70
$9.40K
David P Hochman
25 Sep 2024
See Remarks
Buy indirect
2,000
$4.74
$9.48K
David P Hochman
25 Sep 2024
See Remarks
Buy indirect
1,500
$4.86
$7.29K
David P Hochman
24 Sep 2024
See Remarks
Buy
2,500
$4.91
$12.28K
Eric S Fain
10 Sep 2024
Director
Sell indirect
1,800
$5.34
$9.61K
Darren Sherman
10 Sep 2024
See Remarks
Sell
6,904
$5.31
$36.66K
Eric S Fain
9 Sep 2024
Director
Sell indirect
1,800
$5.43
$9.77K
Darren Sherman
9 Sep 2024
See Remarks
Sell
6,804
$5.48
$37.29K
Darren Sherman
6 Sep 2024
See Remarks
Sell
6,819
$5.65
$38.53K
Eric S Fain
6 Sep 2024
Director
Sell indirect
2,000
$5.64
$11.28K
Darren Sherman
5 Sep 2024
See Remarks
Sell
6,961
$5.85
$40.72K
Darren Sherman
4 Sep 2024
See Remarks
Sell
6,837
$6.10
$41.71K
David P Hochman
14 Aug 2024
See Remarks
Buy
2,500
$5.84
$14.60K
David P Hochman
25 Jun 2024
See Remarks
Buy indirect
1,000
$6.95
$6.95K
William Reed Little
30 May 2024
See Remarks
Buy
4,000
$7.00
$28.00K
Eric A Md Rose
17 May 2023
Director
Exercised, kept
2,325
$1.08
$2.51K
Eric S Fain
10 May 2023
Director
Exercised, kept indirect
2,906
$1.08
$3.14K
Medtronic plc
30 Jan 2023
10% owner
Buy indirect
6,835
$9.28
$63.44K
Roderick Wong
24 Jan 2023
Chief Executive Officer
Buy indirect
1,808,512
$10.00
$18.09M
Roderick Wong
22 Jul 2022
Chief Executive Officer
Buy indirect
1,000,000
$10.01
$10.01M
HSAC 2 Holdings, LLC
6 Aug 2020
10% owner
Buy
450,000
$10.00
$4.50M
Alice Lee
4 Aug 2020
VP Operations, Sec & Treasurer
Buy
10,000
$10.00
$100.00K
Stephanie A Sirota
4 Aug 2020
VP of Corp Stratege and Comm
Buy indirect
20,000
$10.00
$200.00K

What was left out

Form 4 filings counted 160
Amendments (4/A) skipped 18
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 1
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 14,933,734
History held since 6 Aug 2020